Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT01565668 · COMPLETED
Trial details
- NCT number
- NCT01565668
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-03-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.